Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net Income (loss) $ (14,656) $ 594
Adjustments to reconcile net profit (loss) to cash used in operating activities    
Depreciation, amortization, and non-cash lease interest 6,308 1,269
Provision for doubtful accounts 299 205
Reserve for excess and obsolete inventory 374 152
Change in fair value of warrant liabilities (1,221) (170)
Change in fair value of contingent earnout liability (50,982) (42,710)
Stock-based compensation expense 15,620 11,395
Transaction costs expensed 0 1,996
Changes in operating assets and liabilities, net of effects of businesses acquired    
Accounts receivable (3,137) (7,676)
Inventory (12,178) (4,869)
Prepaid expenses 339 (3,901)
Other current assets (2,202) 861
Other assets (939) (185)
Accounts payable and accrued expenses 242 4,317
Other current liabilities (114) (7)
Deferred rent 0 352
Deferred revenue 909 (418)
Other long term liabilities 0 0
Other non-current lease liabilities (3,979) 0
Net cash used in operating activities (65,317) (38,795)
Investing Activities:    
Purchases of property and equipment (5,995) (2,323)
Cash paid for acquisitions, net of cash acquired (35,634) 0
Net cash used in investing activities (41,629) (2,323)
Financing Activities:    
Repayment of debt obligations 0 (5,022)
Proceeds From Merger 0 132,926
Proceeds From P I P E Investment 0 210,000
Repurchase of common stock (45,000)
Payment of transaction costs for the Merger 0 (16,043)
Proceeds from exercise of Series D warrants 0 550
Proceeds from the exercise of common stock options 2,081 1,727
Taxes paid related to net share settlement of equity awards (482) 0
Net cash provided by (used in) financing activities 1,599 (279,138)
Effect of exchange rate changes on cash (21)  
Net change in cash, cash equivalents, and restricted cash (105,368) 238,020
Cash and cash equivalents and restricted cash    
Beginning of year 288,603 58,715
End of period 183,235 296,735
Supplemental disclosures of cash flow information    
Cash and cash equivalents 181,805 296,735
Restricted cash 1,430 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 183,235 296,735
Non-cash financing and investing activities    
Purchase of property and equipment in accounts payable and accrued expenses 2,733 152
Recognition Of Contingent Earnout Liability Related To Earnout Shares 0 123,129
Recognition Of One Public Warrant Acquired As Part Of The Merger In Additional Paid In Capital 0 9,729
Recognition Of Private Placement Warrant Liability Upon Merger 0 5,702
Exercise of common stock warrants, net of shares withheld for exercise 0 1,796
Conversion Of Convertible Preferred Stock Into Common Stock Upon Reverse Recapitalization 0 138,047
Common Stock issued for acquisitions 12,944 0
Additions to right of use assets and liabilities $ 36,451 $ 0